Longitudinal BCR repertoire dynamics reveal the evolution of broadly binding antibodies following heterologous SARS-CoV-2 vaccination and breakthrough infection: a single-donor case study
- 1Shanghai Sci-Tech Inno Center for Infection & Immunity, National Medical Center for Infectious Diseases, Huashan Hospital, Institute of Infection and Health, Fudan University, Shanghai, People's Republic of China
- 2School of Public Health, Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China
- 3Key Laboratory of Neonatal Diseases, Ministry of Health, Children's Hospital of Fudan University, Shanghai, People's Republic of China
Abstract
Continued SARS-CoV-2 antigenic drift and the persistent risk of zoonotic sarbecovirus spillover highlight the need for broadly protective countermeasures. Here, we longitudinally profiled the B cell receptor (BCR) repertoire of a single volunteer who received heterologous booster vaccination followed by Omicron BF.7 breakthrough infection, integrating bulk BCR sequencing with single B cell culture and antibody binding analysis. Breakthrough infection was associated with broadened serum neutralization across SARS-CoV-2 variants and related sarbecoviruses, consistent with recall of antibodies targeting conserved epitopes. Repertoire analysis revealed stage-specific remodelling, with high-affinity binding antibodies shifting from an IGHV1-46-enriched profile after vaccination to preferential representation of IGHV3-30-3 after infection. Isolated monoclonal antibodies exhibited nanomolar-to-picomolar binding affinities to diverse animal-derived sarbecovirus spikes, with broad binding commonly, but not universally, associated with CDRH3 lengths of 14-16 amino acids. Phylogenetic and sequence analyses defined divergent evolutionary trajectories for IGHV1-46 and IGHV3-30-3 lineages, highlighting candidate genetic features that warrant validation in larger cohorts. Together, these findings describe how sequential heterologous antigen exposures can reshape the humoral repertoire in one individual and generate hypotheses for future pan-sarbecovirus antibody and vaccine studies.
Related
- Spatiotemporal heterologous vaccination relies on type I interferons at priming to enhance mucosal immunity
- More Shots on Goal: Heterologous Influenza Prime-Boost Vaccination Decreases the Likelihood of a Negligible Antibody Response to Current or Historical Variants
- Evidence for cross-reactivity and protection against Bundibugyo virus disease after heterologous vaccination: a systematic review and meta-analysis
- Targeting poorly differentiated thyroid cancer with bispecific antibodies and CAR T cells from the human anti-TSHR autoantibody repertoire
- Mass cytometry of early immune remodeling after mRNA booster vaccination reveals exploratory CD4 naive T-cell associations with documented breakthrough infection
BibTeX
@article{qiao2026longitudinal,
title = {{Longitudinal BCR repertoire dynamics reveal the evolution of broadly binding antibodies following heterologous SARS-CoV-2 vaccination and breakthrough infection: a single-donor case study}},
author = {Rui Qiao and Xiaorong Chen and Xuhuan Zhang and Yuchen Shao and Liangjiu Zhang and Luxuan Yang and Yabo Mi and Yinying Lu and Jiayan Li and Yumeng Chen and Hongjie Yu and Ying Wang and Xiaoyu Zhao and Pengfei Wang},
journal = {Emerging Microbes \& Infections},
year = {2026},
month = oct,
doi = {10.1080/22221751.2026.2751804},
url = {https://doi.org/10.1080/22221751.2026.2751804},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Longitudinal BCR repertoire dynamics reveal the evolution of broadly binding antibodies following heterologous SARS-CoV-2 vaccination and breakthrough infection: a single-donor case study
AU - Rui Qiao
AU - Xiaorong Chen
AU - Xuhuan Zhang
AU - Yuchen Shao
AU - Liangjiu Zhang
AU - Luxuan Yang
AU - Yabo Mi
AU - Yinying Lu
AU - Jiayan Li
AU - Yumeng Chen
AU - Hongjie Yu
AU - Ying Wang
AU - Xiaoyu Zhao
AU - Pengfei Wang
PY - 2026
DA - 2026/10/17
JO - Emerging Microbes & Infections
DO - 10.1080/22221751.2026.2751804
UR - https://doi.org/10.1080/22221751.2026.2751804
AB - Continued SARS-CoV-2 antigenic drift and the persistent risk of zoonotic sarbecovirus spillover highlight the need for broadly protective countermeasures. Here, we longitudinally profiled the B cell receptor (BCR) repertoire of a single volunteer who received heterologous booster vaccination followed by Omicron BF.7 breakthrough infection, integrating bulk BCR sequencing with single B cell culture and antibody binding analysis. Breakthrough infection was associated with broadened serum neutralization across SARS-CoV-2 variants and related sarbecoviruses, consistent with recall of antibodies targeting conserved epitopes. Repertoire analysis revealed stage-specific remodelling, with high-affinity binding antibodies shifting from an IGHV1-46-enriched profile after vaccination to preferential representation of IGHV3-30-3 after infection. Isolated monoclonal antibodies exhibited nanomolar-to-picomolar binding affinities to diverse animal-derived sarbecovirus spikes, with broad binding commonly, but not universally, associated with CDRH3 lengths of 14-16 amino acids. Phylogenetic and sequence analyses defined divergent evolutionary trajectories for IGHV1-46 and IGHV3-30-3 lineages, highlighting candidate genetic features that warrant validation in larger cohorts. Together, these findings describe how sequential heterologous antigen exposures can reshape the humoral repertoire in one individual and generate hypotheses for future pan-sarbecovirus antibody and vaccine studies.
SN - 2222-1751
ER -